×

Human monoclonal antibodies specific for glypican-3 and use thereof

  • US 10,640,571 B2
  • Filed: 12/15/2017
  • Issued: 05/05/2020
  • Est. Priority Date: 04/19/2011
  • Status: Active Grant
First Claim
Patent Images

1. An isolated human variable heavy (VH) domain monoclonal antibody that binds glypican-3 (GPC3), comprising the complementarity determining region (CDR) 1, CDR2 and CDR3 sequences of SEQ ID NO:

  • 2.

View all claims
  • 1 Assignment
Timeline View
Assignment View
    ×
    ×